A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
Clinical trial NCT05377333 · COMPLETED
Trial details
- NCT number
- NCT05377333
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-02
- Primary completion
- 2023-11-22
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.